The Dog That Gradually Stops Walking
It begins subtly — a scuffing of the back feet on pavement, a slightly swaying gait, difficulty getting up from rest. Over weeks and months, the hind legs weaken progressively until the dog can no longer support its own weight. Degenerative myelopathy (DM) is one of the most common causes of progressive hind limb paralysis in adult and older dogs, yet it remains widely misunderstood, frequently confused with intervertebral disc disease (IVDD), and — crucially — carries no effective cure. What owners and their vets can do is slow its progression and maximise quality of life for as long as possible.
What Is Degenerative Myelopathy?
Degenerative myelopathy is a progressive, non-inflammatory disease of the spinal cord, primarily affecting the white matter — the nerve fibre tracts — that carry signals between the brain and the rest of the body. The degeneration begins in the thoracic spinal cord and progresses both up towards the brain and down towards the tail, accounting for the characteristic advance from hind limb weakness to paralysis and, in later stages, forelimb involvement.
The disease is associated with a mutation in the SOD1 gene (superoxide dismutase 1), which has also been implicated in a form of amyotrophic lateral sclerosis (ALS) in humans — a parallel that has attracted research interest. The SOD1 mutation exists in at-risk and affected dogs in a homozygous state (two copies), though not all dogs carrying two copies develop the disease, indicating that additional genetic or environmental factors are involved.
Breeds Most Commonly Affected
German Shepherds are the most commonly affected breed and historically gave the disease its original name, German Shepherd degenerative myelopathy. However, DM has since been confirmed in over 100 breeds, with significant prevalence in Pembroke Welsh Corgis, Boxers, Rhodesian Ridgebacks, Chesapeake Bay Retrievers, and Wire Fox Terriers. Large and giant breed dogs are more frequently affected, though no breed should be assumed exempt.
Genetic testing for the SOD1 mutation is available and is relevant for breeding decisions, though a positive result (homozygous) indicates risk rather than certainty of disease.
Why It Is Confused With IVDD
Intervertebral disc disease and degenerative myelopathy can look remarkably similar in the early stages. Both cause progressive hind limb weakness and ataxia in middle-aged to older dogs, and both are common in overlapping breeds. The critical distinctions are:
- Pain: IVDD typically causes spinal pain — yelping, reluctance to move, hunched posture. DM is characteristically painless. A dog with DM may walk on the tops of its feet without apparent discomfort.
- Onset: IVDD often has an acute or subacute onset; DM is insidiously progressive over months.
- Imaging: MRI or myelography in IVDD reveals disc herniation compressing the spinal cord. In DM, imaging is typically unremarkable — or reveals only age-related changes insufficient to explain the clinical signs. This is why DM is often a diagnosis of exclusion.
The distinction matters enormously because IVDD may be amenable to surgical intervention, while DM is not. A dog incorrectly assumed to have DM may be denied surgery that could restore function.
Diagnosis
There is no definitive in-life diagnostic test for DM. Diagnosis is based on the clinical picture — progressive, painless hind limb ataxia and weakness in a breed with known predisposition — combined with advanced imaging to exclude compressive spinal cord disease. Genetic testing for the SOD1 mutation supports but does not confirm the diagnosis. Definitive confirmation currently requires post-mortem histopathology of the spinal cord.
This diagnostic limitation means that owners and vets must make treatment and quality of life decisions with some degree of uncertainty, which makes careful clinical documentation of the disease progression particularly valuable.
Management: Slowing the Decline
Physiotherapy and Exercise
Intensive, regular physiotherapy is the most evidence-supported intervention available for DM. Studies in dogs have demonstrated that those receiving physiotherapy maintain ambulation significantly longer than those that do not. Treatment includes underwater treadmill hydrotherapy, assisted walking, balance exercises, and passive range-of-motion work. The aim is to maintain muscle mass, joint flexibility, and proprioceptive awareness for as long as possible. Consistency is key — daily or near-daily sessions produce better outcomes than infrequent treatment.
Mobility Aids
As hind limb strength declines, mobility aids become essential. Drag bags protect the skin of dogs that knuckle or drag their feet. Hind limb wheelchairs — custom-fitted to the individual dog — allow continued independent mobility and the psychological benefits of exercise and environmental engagement. Many dogs adapt quickly and enthusiastically to wheelchairs. These are not end-of-life concessions; they are quality-of-life tools.
Nursing Care
Dogs with advanced DM require attentive nursing: padded bedding to prevent pressure sores, regular repositioning if recumbent, bladder and bowel management if urinary or faecal incontinence develops, and scrupulous hygiene. The workload increases substantially as the disease progresses to full paralysis and forelimb involvement.
Prognosis and End-of-Life Decisions
DM is progressive and ultimately fatal — there is no reversal. Most dogs progress from early hind limb weakness to paraplegia within 6 to 18 months. Disease then advances to affect forelimbs, and eventually respiratory muscles in some dogs. The disease itself is not painful, but secondary complications — skin sores, infections, the distress of complete immobility — affect welfare in the later stages.
Quality of life assessment should be ongoing throughout the disease course. Many dogs with DM maintain a positive demeanour, enjoy food, social interaction, and wheelchair-assisted activity well into the paralytic phase. The decision to consider euthanasia typically centres on loss of forelimb function, inability to manage incontinence, recurrent infections, or clear evidence of distress rather than paralysis alone.
Working closely with a veterinary neurologist and a physiotherapist experienced in canine rehabilitation gives affected dogs the best chance of a longer, more comfortable course. The disease cannot be stopped, but its impact can be managed — and that management, done well, represents meaningful care.